Literature DB >> 14769608

The use of apraclonidine in the diagnosis of horner syndrome in pediatric patients.

Darron A Bacal1, Susan R Levy.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14769608     DOI: 10.1001/archopht.122.2.276

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


× No keyword cloud information.
  6 in total

Review 1.  Current pharmacologic testing for Horner syndrome.

Authors:  Mansoor Mughal; Reid Longmuir
Journal:  Curr Neurol Neurosci Rep       Date:  2009-09       Impact factor: 5.081

2.  Apraclonidine and my pupil.

Authors:  Melissa Cambron; Heidi Maertens; Luc Crevits
Journal:  Clin Auton Res       Date:  2011-03-08       Impact factor: 4.435

3.  The sensitivity and specificity of 0.5% apraclonidine in the diagnosis of oculosympathetic paresis.

Authors:  F Koc; S Kavuncu; T Kansu; G Acaroglu; E Firat
Journal:  Br J Ophthalmol       Date:  2005-11       Impact factor: 4.638

4.  Safety of apraclonidine eye drops in diagnosis of Horner syndrome in an outpatient pediatric ophthalmology clinic.

Authors:  Amgad A Eldib; Preeti Patil; Ken K Nischal; Ellen R Mitchell; Jamila G Hiasat; Matthew S Pihlblad
Journal:  J AAPOS       Date:  2021-11-02       Impact factor: 1.220

Review 5.  Horner's syndrome, Pseudo-Horner's syndrome, and simple anisocoria.

Authors:  Timothy J Martin
Journal:  Curr Neurol Neurosci Rep       Date:  2007-09       Impact factor: 5.081

6.  Long-Term Follow-Up in Children with Anisocoria: Cocaine Test Results and Patient Outcome.

Authors:  Fabienne C Fierz; Christina Gerth-Kahlert
Journal:  J Ophthalmol       Date:  2017-12-04       Impact factor: 1.909

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.